Vildagliptin/Metformin +pharma 50mg/850mg film-coated tablets Malta - English - Medicines Authority

vildagliptin/metformin +pharma 50mg/850mg film-coated tablets

+pharma arzneimittel gmbh hafnerstrasse 211 8054 graz , austria - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Vildagliptin/Metformin +pharma 50mg/1000mg film-coated tablets Malta - English - Medicines Authority

vildagliptin/metformin +pharma 50mg/1000mg film-coated tablets

+pharma arzneimittel gmbh hafnerstrasse 211 8054 graz , austria - film-coated tablet - metformin hydrochloride 1000 mg vildagliptin 50 mg - drugs used in diabetes

Tadalafil Aristo Pharma 5mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 5mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Tadalafil Aristo Pharma 10mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 10mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 10 mg - urologicals

Tadalafil Aristo Pharma 20mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 20mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Dutasteride/Tamsulosin Q Pharma, 0.5mg/0.4mg Hard Capsules Malta - English - Medicines Authority

dutasteride/tamsulosin q pharma, 0.5mg/0.4mg hard capsules

laboratorios q pharma, s.l c/ moratín, 15 entlo. oficinas 6-7, alicante 03008, spain - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

PHARMA-Q ADRENALINE INJECTION 1 mg/ml South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharma-q adrenaline injection 1 mg/ml

pharma-q holdings (pty) ltd - injection - see ingredients - each 1 ml liquid contains epinephrine bitartrate 1,80 mg equivalent to epinephrine 1 mg

PHARMAGABAPENTIN gabapentin 300 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmagabapentin gabapentin 300 mg capsule blister pack

pharmacor pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

PHARMAGABAPENTIN gabapentin 400 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmagabapentin gabapentin 400 mg capsule blister pack

pharmacor pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

PHARMAGABAPENTIN gabapentin 100 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmagabapentin gabapentin 100 mg capsule blister pack

pharmacor pty ltd - gabapentin, quantity: 100 mg - capsule, hard - excipient ingredients: lactose; purified talc; maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.